.jpg)
.png)
All
Medical literature is replete with the use of more complex statistics these days, and many of our practice guidelines require more and more rigorously conducted studies with sophisticated statistics to be considered. It is important that clinical lipid specialists and others in the field of... more
Although an interventional cardiologist from the beginning of coronary intervention, I have been passionate about clinical lipidology since the mid 1990's and became a Diplomate of the American Board of Clinical Lipidology in 2006. The NLA/PLA has enhanced my practice and changed my focus to... more
The NLA’s USAGE Campaign, which launched in 2012 as a joint initiative by the NLA, Kowa Pharmaceuticals America and Eli Lilly & Co. has won five nationally renowned public relations awards.
The United States Preventive Services Task Force (USPSTF) recently released its Final Recommendation Statement on Lipid Disorders in Children and Adolescents: Screening. NLA leadership disagrees with this release and communicated twice to USPSTF about the implications of this statement. The... more
On Friday morning, the U.S. House of Representatives passed an amended version of H.R. 4015 (237-182) that would repeal the flawed Sustainable Growth Rate (SGR) formula that serves as the underpinning of Medicare physician payment and provide for other Medicare payment reforms. Unfortunately,... more
h3{ margin-bottom:10px; } Core Curriculum Committee The Core Curriculum Committee is responsible for periodically reviewing the NLA's Core Curriculum in Lipidology and recommending changes based on current best evidence and practice.... more
I feel so fortunate to be able to write this. I am honored to lead the NLA as the 2022-2023 president. Having been involved in the NLA for nearly its full 20-year history, I look forward to helping shape the organization’s efforts for the next year. The expansion of the Diversity, Equity and... more
Statins prevent atherosclerotic cardiovascular diseases (ASCVD). Hepatic injury (my patients most feared effect) occurs in ≤1 percent and is similar on placebo. Elevated hepatic transaminases typically resolve spontaneously and mostly are a result of dyslipidemia causing hepatosteatosis and/or... more
The National Lipid Association (NLA) announced on Thursday the recipients of its inaugural Junior Faculty Research Awards for Clinical Science and Basic Science.
Historically, familial hypercholesterolemia (FH), remains an underdiagnosed and undertreated disease. It is estimated that 90% of individuals with FH remain undiagnosed in the United States.(1) FH patients have ten to twenty-fold higher risk of cardiovascular disease. However, cardiovascular risk... more